EDIT - I see ..."A potential deal would value the biotech company at $3.1 billion, representing a 33% premium to Forty Seven stock's closing price on Thursday, Porges said in a report. He kept his market perform rating and 67 price target on Gilead stock."
Where are you getting the 30% premium? Is that in the article or is that just based on FTSV price AH? The article said approached by other suitors as well which would suggest higher than a 30% premium.
Also volume really picked up during the week and FTSV wasnt really hit on the FTSV news, it seems like this news got out earlier in the week.
Market Data 
Markets 
AI
